Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harvey Alter

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Digestive Diseases and Sciences|April 6, 2023
Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral TherapyNehna Abdul Majeed, Ahmad Samer Alawad, Kin Seng Liem, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2016
Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissueDjamila Harouaka, Ronald E Engle, Kurt Wollenberg, et al.
Hepatology (Baltimore, Md.)|February 15, 2011
In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virusPhilip Meuleman, Jens Bukh, Lieven Verhoye, et al.
Gastroenterology|January 4, 2003
Progression of fibrosis in chronic hepatitis CMarc G Ghany, David E Kleiner, Harvey Alter, et al.
Journal of Virology|December 28, 2002
The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunityMichael Thomson, Michelina Nascimbeni, Michael B Havert, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2005
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1Jean-Christophe Meunier, Ronald E Engle, Kristina Faulk, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2013
Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virusLu Deng, Lilin Zhong, Evi Struble, et al.
Plos One|January 9, 2014
A neutralization epitope in the hepatitis C virus E2 glycoprotein interacts with host entry factor CD81Zhong Zhao, Lilin Zhong, Elizabeth Elrod, et al.
Hepatology (Baltimore, Md.)|June 5, 2013
Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodiesJannie Pedersen, Thomas H R Carlsen, Jannick Prentoe, et al.
Transfusion|July 2, 2013
Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody responseRachael P Jackman, Xutao Deng, Douglas Bolgiano, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Digestive Diseases and Sciences|April 6, 2023
Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral TherapyNehna Abdul Majeed, Ahmad Samer Alawad, Kin Seng Liem, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2016
Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissueDjamila Harouaka, Ronald E Engle, Kurt Wollenberg, et al.
Hepatology (Baltimore, Md.)|February 15, 2011
In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virusPhilip Meuleman, Jens Bukh, Lieven Verhoye, et al.
Gastroenterology|January 4, 2003
Progression of fibrosis in chronic hepatitis CMarc G Ghany, David E Kleiner, Harvey Alter, et al.
Journal of Virology|December 28, 2002
The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunityMichael Thomson, Michelina Nascimbeni, Michael B Havert, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2005
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1Jean-Christophe Meunier, Ronald E Engle, Kristina Faulk, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2013
Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virusLu Deng, Lilin Zhong, Evi Struble, et al.
Plos One|January 9, 2014
A neutralization epitope in the hepatitis C virus E2 glycoprotein interacts with host entry factor CD81Zhong Zhao, Lilin Zhong, Elizabeth Elrod, et al.
Hepatology (Baltimore, Md.)|June 5, 2013
Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodiesJannie Pedersen, Thomas H R Carlsen, Jannick Prentoe, et al.
Transfusion|July 2, 2013
Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody responseRachael P Jackman, Xutao Deng, Douglas Bolgiano, et al.
Pageof 3